OP White Papers - random
-
mRNA Therapeutic Development Through Enhanced IVT Capping Efficiency
4/16/2025
See how Codex HiCap RNA Polymerase supports the production of high-performance synthetic mRNA, paving the way for next-generation mRNA therapies.
-
Nucleic Acid-LNP Ultrafiltration And Diafiltration
5/5/2026
Downstream filtration can make or break LNPs at scale. See how membrane format, loading, and shear affect recovery and stability — and how alternative TFF lowers scale‑up risk.
-
Manufacturing Of Cytotoxic And Non-Cytotoxic Drugs In A Multiproduct Facility
10/16/2024
The experience and expertise of the CMO is crucial to avoid the risk of cross-contamination of the drug product, as failures or weaknesses in this process can pose risk to the end-user.
-
Performance Characteristics Of The Mobius® ADC Reactor For Conjugation
10/22/2024
Explore results from a series of studies evaluating the mixing performance of an innovative ADC reactor during the conjugation step utilizing a model fluid.
-
The Case For Non-Viral Circular Single-Stranded HDR Donors
8/13/2026
Enable efficient, low-toxicity genome editing without viral vectors. This cell-free circular ssDNA platform preserves stem cell fitness while supporting scalable manufacturing.
-
Unlocking Durable Allogeneic Cell Therapy
5/13/2026
Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.
-
Spray Dry Biologics For Oral Dosage Forms
5/15/2026
Spray drying enables stable oral delivery of biologics by creating protective dry powders, improving bioavailability, stability, and targeted release compared with traditional formulation methods.
-
Starting With The End In Mind
7/16/2026
Complex biologics need scalable, GMP-ready development from the start. Early decisions, scientific continuity, and strong partnerships help reduce delays and rework.
-
Methods For Determining Equipment Capability Of Freeze-Dryers
10/16/2024
Observe two experimental methods for determining choked flow: the minimum controllable pressure method and the choke point method.
-
A Scalable Platform To Revolutionize Gene Therapy Manufacturing
11/22/2024
Discover how our innovative rAAV production platform can revolutionize your gene therapy pipeline with unparalleled yield, quality, and scalability.